The combination of TQ and gemcitabine contributes to increasing apoptosis and inhibiting tumor growth in pancreatic cancer via inactivation of Akt/mTOR/S6 signaling pathways by up-regulation of PTEN [27]. This evidence concerns the gene MTOR and familial pancreatic carcinoma.